Literature DB >> 6285362

Covalent crosslinking of angiotensin II to its binding sites in rat adrenal membranes.

S Paglin, J D Jamieson.   

Abstract

To identify the molecular components of the angiotensin II (AII) receptor in the adrenal cortex, we have covalently linked 125I-labeled AII (125I-AII) to its binding sites by using the chemical crosslinker disuccinimidyl suberate. Membrane fractions from rat adrenal tissue were incubated with 125I-AII, washed, and treated with disuccinimidyl suberate. NaDodSO4/polyacrylamide gel electrophoresis carried out under reducing conditions followed by autoradiography showed that a major polypeptide(s) with an average Mr of 116,000 was covalently tagged with 125I-AII. Proteins with Mr of 54,000 and 45,000 were also lightly labeled. Labeling of the Mr 116,000 species was specific in that it could be abolished by prior incubation of the membranes with [Sar1,Leu8]AII or unlabeled AII. Labeling of the smaller proteins was less affected by prior incubation with [Sar1,Leu8]AII. Experiments in which crosslinking was carried out in the presence of a variety of protease inhibitors indicated that the Mr 116,000 species is not an enzyme involved in AII degradation. Gel electrophoresis under nonreducing conditions showed that this component is not derived from larger disulfide-linked entities. We suggest that the Mr 116,000 moiety is a part of the receptor system for AII. The relationship, if any, of the Mr 54,000 and 45,000 peptides to the AII receptor remains unknown.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6285362      PMCID: PMC346502          DOI: 10.1073/pnas.79.12.3739

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Structures and activities of protease inhibitors of microbial origin.

Authors:  H Umezawa
Journal:  Methods Enzymol       Date:  1976       Impact factor: 1.600

2.  Formation of angiotensin III by angiotensin-converting enzyme.

Authors:  A T Chiu; J W Ryan; J M Stewart; F E Dorer
Journal:  Biochem J       Date:  1976-04-01       Impact factor: 3.857

3.  Inhibitors of glucagon inactivation. Effect on glucagon--receptor interactions and glucagon-stimulated adenylate cyclase activity in liver cell membranes.

Authors:  B Desbuquois; F Krug; P Cuatrecasas
Journal:  Biochim Biophys Acta       Date:  1974-03-20

4.  Properties of angiotensin II receptors in the bovine and rat adrenal cortex.

Authors:  H Glossmann; A J Baukal; K J Catt
Journal:  J Biol Chem       Date:  1974-02-10       Impact factor: 5.157

Review 5.  Pharmacology of angiotensin.

Authors:  D Regoli; W K Park; F Rioux
Journal:  Pharmacol Rev       Date:  1974-06       Impact factor: 25.468

6.  Angiotensin receptors.

Authors:  S Y Lin; T L Goodfriend
Journal:  Am J Physiol       Date:  1970-05

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Aldosterone production by isolated adrenal glomerulosa cells: stimulation by physiological concentrations of angiotensin II.

Authors:  P Fredlund; S Saltman; K J Catt
Journal:  Endocrinology       Date:  1975-12       Impact factor: 4.736

9.  Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents.

Authors:  M A Ondetti; B Rubin; D W Cushman
Journal:  Science       Date:  1977-04-22       Impact factor: 47.728

10.  Secretion granules of the rabbit parotid gland. Isolation, subfractionation, and characterization of the membrane and content subfractions.

Authors:  J D Castle; J D Jamieson; G E Palade
Journal:  J Cell Biol       Date:  1975-01       Impact factor: 10.539

View more
  13 in total

1.  Introductory remarks.

Authors:  Luigi F Agnati; Kjell Fuxe
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 2.  Intramembrane receptor-receptor interactions: a novel principle in molecular medicine.

Authors:  K Fuxe; M Canals; M Torvinen; D Marcellino; A Terasmaa; S Genedani; G Leo; D Guidolin; Z Diaz-Cabiale; A Rivera; L Lundstrom; U Langel; J Narvaez; S Tanganelli; C Lluis; S Ferré; A Woods; R Franco; L F Agnati
Journal:  J Neural Transm (Vienna)       Date:  2006-10-27       Impact factor: 3.575

3.  Hydrodynamic properties of the angiotensin II receptor from bovine adrenal zona glomerulosa.

Authors:  J J Rondeau; N McNicoll; E Escher; S Meloche; H Ong; A De Léan
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

4.  Identification of the receptor for erythropoietin by cross-linking to Friend virus-infected erythroid cells.

Authors:  S T Sawyer; S B Krantz; J Luna
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

5.  Direct cross-linking of 125I-labeled glucagon to its membrane receptor by UV irradiation.

Authors:  V Iwanij; K C Hur
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

6.  The rat liver vasoactive intestinal peptide binding site. Molecular characterization by covalent cross-linking and evidence for differences from the intestinal receptor.

Authors:  A Couvineau; M Laburthe
Journal:  Biochem J       Date:  1985-01-15       Impact factor: 3.857

7.  Isolation of an angiotensin II-binding protein from liver.

Authors:  I Sen; H G Bull; R L Soffer
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

8.  Structures of the somatotropin receptor and prolactin receptor on rat hepatocytes characterized by affinity labelling.

Authors:  K Yamada; D B Donner
Journal:  Biochem J       Date:  1984-06-01       Impact factor: 3.857

9.  Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin Receptors.

Authors:  Rishi K Somvanshi; Ujendra Kumar
Journal:  Pharmaceuticals (Basel)       Date:  2012-04-27

10.  Receptor oligomerization: from early evidence to current understanding in class B GPCRs.

Authors:  Stephanie Y L Ng; Leo T O Lee; Billy K C Chow
Journal:  Front Endocrinol (Lausanne)       Date:  2013-01-04       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.